205 related articles for article (PubMed ID: 33749913)
1. Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B
Welty FK; Schulte F; Alfaddagh A; Elajami TK; Bistrian BR; Hardt M
FASEB J; 2021 Apr; 35(4):e21448. PubMed ID: 33749913
[TBL] [Abstract][Full Text] [Related]
2. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
3. Effect of Eicosapentaenoic Acid/Docosahexaenoic Acid on Coronary High-Intensity Plaques Detected Using Noncontrast T1-weighted Imaging: The AQUAMARINE EPA/DHA Randomized Study.
Nakao K; Noguchi T; Miura H; Asaumi Y; Morita Y; Takeuchi S; Matama H; Sawada K; Doi T; Hosoda H; Nakashima T; Honda S; Fujino M; Yoneda S; Kawakami S; Nagai T; Nishihira K; Kanaya T; Otsuka F; Nakanishi M; Kataoka Y; Tahara Y; Goto Y; Kusano K; Yamamoto H; Omae K; Ogawa H; Yasuda S
J Atheroscler Thromb; 2024 Feb; 31(2):122-134. PubMed ID: 37704431
[TBL] [Abstract][Full Text] [Related]
4. Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis.
Marchand NE; Choi MY; Oakes EG; Cook NR; Stevens E; Gomelskaya N; Kotler G; Manson JE; Lasky-Su J; Mora S; Lee IM; Tatituri R; Costenbader KH
Prostaglandins Leukot Essent Fatty Acids; 2023 Mar; 190():102542. PubMed ID: 36773395
[TBL] [Abstract][Full Text] [Related]
5. Eicosapentaenoic and docosahexaenoic acid supplementation and coronary artery calcium progression in patients with coronary artery disease: A secondary analysis of a randomized trial.
Hariri E; Asbeutah AA; Malik A; Amangurbanova M; Chedid G; Daher R; Al Hammoud M; Welty FK
Atherosclerosis; 2023 Dec; 387():117388. PubMed ID: 38056242
[TBL] [Abstract][Full Text] [Related]
6. Imbalanced serum levels of resolvin E1 (RvE1) and leukotriene B4 (LTB4) may contribute to the pathogenesis of atherosclerosis.
Molaie M; Lotfi R; Heidari Moghadam R; Rezaiemanesh A; Karaji AG; Salari F
Prostaglandins Other Lipid Mediat; 2023 Dec; 169():106781. PubMed ID: 37704124
[TBL] [Abstract][Full Text] [Related]
7. Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial).
Keeley EC; Li HJ; Cogle CR; Handberg EM; Merz CNB; Pepine CJ
Am J Cardiol; 2022 Jan; 162():1-5. PubMed ID: 34728061
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 (
Djuricic I; Calder PC
Nutrients; 2024 Mar; 16(7):. PubMed ID: 38612996
[TBL] [Abstract][Full Text] [Related]
9. Synbiotic
Speckmann B; Wagner T; Jordan PM; Werz O; Wilhelm M; Tom Dieck H; Schön C
Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732601
[TBL] [Abstract][Full Text] [Related]
10. Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics.
English JT; Norris PC; Hodges RR; Dartt DA; Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2017 Feb; 117():17-27. PubMed ID: 28237084
[TBL] [Abstract][Full Text] [Related]
11. The Role of Resolvins: EPA and DHA Derivatives Can Be Useful in the Prevention and Treatment of Ischemic Stroke.
Tułowiecka N; Kotlęga D; Prowans P; Szczuko M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076354
[TBL] [Abstract][Full Text] [Related]
12. The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial.
Alfaddagh A; Elajami TK; Saleh M; Elajami M; Bistrian BR; Welty FK
J Clin Lipidol; 2018; 12(4):937-947.e2. PubMed ID: 29752179
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention.
Alfaddagh A; Kapoor K; Dardari ZA; Bhatt DL; Budoff MJ; Nasir K; Miller M; Welty FK; Miedema MD; Shapiro MD; Tsai MY; Blumenthal RS; Blaha MJ
Atherosclerosis; 2022 Jul; 353():11-19. PubMed ID: 35759823
[TBL] [Abstract][Full Text] [Related]
14. Regression of Coronary Fatty Plaque and Risk of Cardiac Events According to Blood Pressure Status: Data From a Randomized Trial of Eicosapentaenoic Acid and Docosahexaenoic Acid in Patients With Coronary Artery Disease.
Welty FK; Hariri E; Asbeutah AA; Daher R; Amangurbanova M; Chedid G; Elajami TK; Alfaddagh A; Malik A
J Am Heart Assoc; 2023 Sep; 12(18):e030071. PubMed ID: 37681568
[TBL] [Abstract][Full Text] [Related]
15. Adiposity associates with lower plasma resolvin E1 (Rve1): a population study.
Barden A; Shinde S; Beilin LJ; Phillips M; Adams L; Bollmann S; Mori TA
Int J Obes (Lond); 2024 May; 48(5):725-732. PubMed ID: 38347128
[TBL] [Abstract][Full Text] [Related]
16. Race-based and sex-based differences in bioactive lipid mediators after myocardial infarction.
Halade GV; Kain V; Dillion C; Beasley M; Dudenbostel T; Oparil S; Limdi NA
ESC Heart Fail; 2020 Aug; 7(4):1700-1710. PubMed ID: 32363774
[TBL] [Abstract][Full Text] [Related]
17. Increased Demand of Obese Women for Protectins, Maresin, and Resolvin D1 in the Last Trimester of Pregnancy.
Szczuko M; Szwec-Nadworna N; Palma J; Tomasik M; Ziętek M
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892415
[TBL] [Abstract][Full Text] [Related]
18. Enriched Marine Oil Supplement Increases Specific Plasma Specialized Pro-Resolving Mediators in Adults with Obesity.
Al-Shaer AE; Regan J; Buddenbaum N; Tharwani S; Drawdy C; Behee M; Sergin S; Fenton JI; Maddipati KR; Kane S; Butler E; Shaikh SR
J Nutr; 2022 Jul; 152(7):1783-1791. PubMed ID: 35349683
[TBL] [Abstract][Full Text] [Related]
19. Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery.
Halade GV; Black LM; Verma MK
Biotechnol Adv; 2018; 36(4):935-953. PubMed ID: 29499340
[TBL] [Abstract][Full Text] [Related]
20. A high docosahexaenoic acid diet alters lung inflammation and recovery following repetitive exposure to aqueous organic dust extracts.
Ulu A; Burr A; Heires AJ; Pavlik J; Larsen T; Perez PA; Bravo C; DiPatrizio NV; Baack M; Romberger DJ; Nordgren TM
J Nutr Biochem; 2021 Nov; 97():108797. PubMed ID: 34126202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
